André Muller - Actelion
Next up is Swiss firm Actelion who has appointed André Muller as Chief Financial Officer, succeeding Andrew Oakley who is to leave the company to pursue other activities.
“He brings vast experience as a pharmaceutical finance executive and I am confident that André will make a significant contribution to Actelion's continued success,” said Actelion’s CEO, Dr. Jean-Paul Clozel.